 Corporate Presentation to Highlight Companys Gene Therapies for Cancer and Diabetes AUSTIN, Texas , May 19, 2022 PRNewswire -- Genprex, Inc. Genprex or the Company NASDAQ: GNPX, a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that its President and Chief Executive Officer, Rodney Varner, will be providing a virtual overview of the Companys gene therapies for cancer and diabetes to investors at the following conference in May 2022. Event: H.C. 